Sonnet Biotherapeutics Holdings Inc Cash Flow Quality Index
Sonnet Biotherapeutics Holdings Inc cash flow quality index. Sonnet Biotherapeutics Holdings Inc (SONN) has a Cash Flow Quality Index of 1.98x as of March 2024. Operating cash flow of $723.79K exceeds net income of $365.43K, indicating high earnings quality where cash backs reported profits. See Sonnet Biotherapeutics Holdings Inc (SONN) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Sonnet Biotherapeutics Holdings Inc Cash Flow Quality Index by Year (None–None)
Sonnet Biotherapeutics Holdings Inc cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Sonnet Biotherapeutics Holdings Inc. For the full cash flow conversion analysis, see cash efficiency ratio of Sonnet Biotherapeutics Holdings Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|